Caprodat en es it fr

Caprodat Brand names, Caprodat Analogs

Caprodat Brand Names Mixture

  • No information avaliable

Caprodat Chemical_Formula


Caprodat RX_link

Caprodat fda sheet

Caprodat msds (material safety sheet)

Caprodat Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Caprodat Molecular Weight

260.33 g/mol

Caprodat Melting Point

92-93 oC

Caprodat H2O Solubility

0.3 mg/ml

Caprodat State


Caprodat LogP


Caprodat Dosage Forms


Caprodat Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Caprodat Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Caprodat Absorption

No information avaliable

Caprodat side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Caprodat Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Caprodat Organisms Affected

Humans and other mammals